Pregnant mom with family

COVID-19 worsens maternal, fetal outcomes, studies find

Poor birth outcomes occurred even in women who weren't severely ill with COVID-19.

Federal COVID vaccine photo op

Supreme Court blocks COVID vaccine mandate for large employers

The Court allowed a mandate for workers at federally funded healthcare facilities.

Older man with hat getting vaccinated

Studies: COVID vaccines effective, with limited waning

In 1 of the 3 studies, vaccination was 98% protective against ICU stay and life support in teens.

Mask wearing outside in India

India's COVID-19 cases surge as parts of Europe eye easing restrictions

India's cases have spiked 30-fold in a month, fueled by the highly transmissible Omicron variant.

Baby feet in hospital bassinet

Study finds babies with low-risk deliveries shouldn't need antibiotics

Yet 80% of low-risk newborns got antibiotics, and for similar durations as high-risk infants.


University of Minnesota, Mayo building aerial view

Dec 30 2021
Washington Post 
editorial on how the current omicron surge represents one of the greatest public health challenges of our lifetime, by Director Michael Osterholm, PhD, MPH, and Ezekiel J. Emanuel.

Dec 11 2021
Director Michael Osterholm, PhD, MPH, was interviewed by CNN to discuss the latest variants, the importance of boosters, and what's next for the COVID-19 pandemic.

Dec 6 2021
Director Michael Osterholm, PhD, MPH, spoke with Time Magazine regarding the implications for organizations of the new Omicron variant.

Dec 1 2021
Background Analysis on Progress Toward Meeting Goals and Objectives in the National Action Plan for Combating Antibiotic-Resistant Bacteria (2015-2020) was authored by CIDRAP staff (Kristine Moore, MD, MPH, & Anje Mehr, MPH) in support of the National Academies of Sciences, Engineering, and Medicine consensus study to examine and quantify the long-term medical and economic impacts of increasing antimicrobial resistance in the United States. 

More Inside CIDRAP


Jan 14, 2022
  • Spending on ivermectin for COVID-19
  • COVID monoclonal antibody combo
  • CWD in Alabama for first time
  • US flu declines slightly
  • Polio in 2 nations
Jan 13, 2022
  • First human trial for new E coli drug
  • More H5N6 avian flu cases, deaths

Stewardship / Resistance Scan

Jan 14, 2022
  • Fosfomycin for UTIs
  • Candida auris resistance


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

The Osterholm Quote

"The question is how long will [COVID vaccine booster] protection last, we’re not sure. At this point, we will continue to do studies monitoring people to see both when their antibody levels drop, but also more importantly in the community, when do we see potential breakthrough infections occurring. At what stage following your immunization and your previous infectious status does that happen?”